SCHEMBL5702999

SCHEMBL5702999

CCOc1ccc(C=NN=C(N)N)cc1OCC

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 5/20 0.75
▸ POLB P06746 3/20 0.75
▸ MAPT P10636 3/20 0.75
▸ MITF O75030 2/20 0.75
▸ LMNA P02545 2/20 0.75
▸ SMN1; SMN2 Q16637 2/20 0.75
▸ GAA P10253 2/20 0.75
▸ MAPK1 P28482 1/20 0.75
▸ HTT P42858 1/20 0.75
▸ UBE2N P61088 2/20 0.67
▸ MEN1 O00255 1/20 0.59
▸ NPC1 O15118 1/20 0.58
▸ RAB9A P51151 1/20 0.58
▸ GRIN2D O15399 7/20 0.57
▸ GRIN3B O60391 7/20 0.57
▸ GRIN1 Q05586 7/20 0.57
▸ GRIN2A Q12879 7/20 0.57
▸ GRIN2B Q13224 7/20 0.57
▸ GRIN2C Q14957 7/20 0.57
▸ GRIN3A Q8TCU5 7/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22830618 0.87 KMT2A (1.00) KMT2APOLBMAPTMITFLMNA
Hydrochloric Acid SCHEMBL5703164 0.78 GRIN2D (0.69) KMT2AMAPTLMNASMN1; SMN2HTT
SCHEMBL5702988 0.75 KMT2A (0.56) KMT2AMAPTLMNASMN1; SMN2GAA
SCHEMBL5702992 0.75 KMT2A (0.56) KMT2AMAPTLMNASMN1; SMN2GAA
SCHEMBL4940997 0.75 GAA (0.64) KMT2APOLBMAPTSMN1; SMN2GAA
SCHEMBL4941002 0.75 GAA (0.64) KMT2APOLBMAPTSMN1; SMN2GAA
Hydrochloric Acid SCHEMBL5703137 0.74 CCR5 (0.70) TLR4
SCHEMBL2608363 0.74 MEN1 (1.00) KMT2APOLBMAPTGAAMEN1
SCHEMBL2834159 0.73 MAPT (0.63) KMT2APOLBMAPTMITFLMNA
SCHEMBL2834157 0.73 MAPT (0.63) KMT2APOLBMAPTMITFLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1687641-A2 TREATING NEUROPATHIC PAIN WITH NEUROPEPTIDE FF RECEPTOR 2 AGONISTS Acadia Pharmaceuticals Inc. (US) 2006-08-09 — — EP disclosed
WO-2005031000-A2 TREATING NEUROPATHIC PAIN WITH NEUROPEPTIDE FF RECEPTOR 2 AGONISTS ACADIA PHARMACEUTICALS INC. (US) 2005-04-07 — — WO disclosed
Send feedback